Tinzaparin: excess mortality in elderly patients with renal failure. Unfractionated heparin is best in this setting.
D000368:Aged; D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000401:mortality; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000401:mortality; D000078222:Tinzaparin; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000401:mortality
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D000078222:Tinzaparin; D006493:Heparin